- About About
Medical Patient Resources Cannabis Care Certification Patient's Guide to Medical Cannabis Patient's Guide to CBD Talking to your doctor Become a Legal Medical Marijuana Patient The Medical Cannabis Patient’s Guide for U.S. Travel Guide to Using Medical Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Arthritis and Medical Cannabis Cancer and Medical Cannabis Chronic Pain and Medical Cannabis Gastrointestinal Disorders and Medical Cannabis HIV/AIDS and Medical Cannabis Movement Disorders and Medical Cannabis Multiple Sclerosis and Medical Cannabis Aging and Medical Cannabis Veterans and Medical Cannabis Medical Marijuana Conditions in Your Area Growing Cannabis Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources Medical Cannabis Continuing Medical Education (CME) Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Policy Positions Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Data Quality Act Briefs Fact Sheet on ASA's Data Quality Act Petition to HHS ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2021 State of the States Cannabis and Cannabis Resin- Critical Review Preparation Document Medical Cannabis in America
- News News
- Join Join
Contact: Hilary McQuie 510.251.1856
NATIONWIDE -- In the continued push to resolve the state-federal conflict over medical marijuana laws, patients and advocates will rally at regional outposts of federal Health and Human Services. The events will occur simultaneously in seven cities nationwide to demand that science and public health prevail when HHS makes its decision on petition requests to reschedule marijuana. Currently, ten states have laws permitting patients to legally use marijuana with a doctor’s recommendation, but these laws are at odds with the federal prohibition that categorizes marijuana as more dangerous than cocaine or amphetamines.
Americans for Safe Access, the national medical marijuana advocacy group responsible for the protests, is one 2002 petitioner to HHS to reclassify marijuana. The group also launched a legal challenge to HHS in 2004 to correct published medical marijuana misinformation under the Data Quality Act (DQA), a little-known law that requires federal agencies to rely on sound science. According to group spokespeople, responses by HHS to both petitions are long overdue.
WHAT: Rally To Reclassify Marijuana
WHERE: Health and Human Services (HHS) offices in Washington DC, Philadelphia, Dallas, Kansas City, Denver, San Francisco & Seattle. (For addresses, see http://safeaccessnow.org/article.php?id=2564)
WHEN: Wednesday, October 26, 2005 - 12 Noon
WHO: Members of Americans for Safe Access (ASA), the largest national grassroots coalition working to protect the rights of patients and doctors to legally use marijuana for medical purposes.
WHY: Patients, medical professionals and advocates are calling on HHS to listen to scientific research and admit marijuana has medical use. If the patient-advocacy group prevails in its DQA petition, the Department of Health and Human Services will have to change its tune on medical marijuana and publicly admit that marijuana is now routinely used for medical treatment, clearing the way for doctors to prescribe it to their patients. According to both petitions, public health must prevail when it comes to marijuana law, since established research, federal reports and patient experience all show marijuana works for pain, nausea, loss of appetite, anxiety, and spasticity, the severe muscle spasms associated with Multiple Sclerosis, spinal injury and other conditions.